INTRODUCTION
Hepatic L-alanine: glyoxylate aminotransferase 1 (AGT1), which is a homodimer with a subunit Mr of approx. 42000 [1-31, catalyses the irreversible transamination of glyoxylate to glycine with L-alanine as the amino-group donor [1, 4, 5] . The intracellular localization of AGT1 is species-dependent. It is found in peroxisomes in primates (including humans) and lagomorphs, mitochondria in carnivores, and in both organelles in rodents [2, 3, [6] [7] [8] .
In the lethal autosomal recessive disease primary hyperoxaluria type 1 (PH 1), hepatic peroxisomal AGT1 is deficient [9] . Although most PH 1 patients have a complete, or nearly complete, absence of AGTI, a considerable proportion (18/45 ; C. J. Danpure, unpublished work) have significant residual enzyme activity (5-50 % of normal levels). In at least nine of these patients the disease appears to be caused by a trafficking defect in which AGTl is diverted from the peroxisomes to the mitochondria [10] .
At least in humans, its peroxisomal localization would appear to be essential to detoxify glyoxylate efficiently [11] . In PHI patients with no AGT1 activity or with AGT1 localized in the mitochondria instead of the peroxisomes, failure to transaminate glyoxylate within the peroxisome allows the accumulated glyoxylate to be oxidized to oxalate [9, 10] . The very low solubility of calcium oxalate causes all the pathological sequelae of PH1 (e.g. severe urolithiasis) [12] . In an attempt to understand the mechanisms by which AGT1 is variably targeted to peroxisomes and/or mitochondria, the sequence of human peroxisomal AGT1 cDNA has been determined and compared with that of rat mitochondrial AGT1 cDNA [13] .
EXPERIMENTAL
Cloning and sequencing of human peroxisomal AGT1 cDNA A fragment of rat mitochondrial AGT1 cDNA (1164 bp, 66-1230 [131) was prepared by the polymerase chain reaction (PCR), using an Amplitaq kit (Cetus) with 1.5 mM-MgCl2 and 0.5 mM-dNTPs and synthetic oligonucleotides (5'-ATGGGC-TCGCACCAGCTGCTG-3' and 5'-AGGACAATGTTGCAG-GGCCTC-3') based on the published sequence [13] , as primers. The PCR product was cut out from a 1.5%-agarose gel and electroeluted. A human liver Agtl 1 cDNA library (5 x I05 recombinant plaques; Clontech) was screened with the fragment as probe at low stringency by plaque hybridization in 6 x SSC/ 10 mM-EDTA/5 x Denhardt's solution/0.5 % SDS/denatured salmon sperm DNA (100 ,g/ml) at 42°C, and washing three times in 1 x SSC at 45°C for 10 min. Ten positive clones were plaque-purified. Phage DNA was obtained by the platelysate method and digested with restriction endonuclease EcoRl and tested for cross-hybridization of the insert by Southern blotting [14] . All clones cross-hybridized to each other. The longest insert (A6-18; 1.25 kb) was subcloned into pBluescript KS(+) and sequenced. It did not contain the entire coding region, so an additional clone (H1-2, 1.6 kb) was selected from a HepG2 cDNA Agtl 1 library (obtained from Dr. M. Krangel, Dana-Farber Cancer Institute, Boston, MA, U.S.A.). The DNA sequences were determined in both directions with a series of overlapping deletion clones [15] by the dideoxynucleotide-chaintermination method [16] using adenosine 5'-[cz-thio]triphosphate labelled at the a-thio position with 3S.
Northern-blot analysis of poly(A)+ mRNA from the livers of various PH1 patients and control subjects Total RNA was extracted from liver stored in liquid N2 by the guanidinium isothiocyanate/caesium chloride method [17] . Poly(A)+ mRNA was prepared by oligo(dT)-cellulose (BCL) column chromatography [18] , and 0.5 4ug samples were fractionated by electrophoresis through 1 These sequence data will appear in the EMBL/GenBank/DDBJ Nucleotide Sequence Databases.
Vol. 268 517 hybridized in 6 x SSC/O. 1 0 SDS/50 00 deionized formamide/ albumin cDNA as an internal loading control. The probes were 10 x Denhardt's solution/sonicated and boiled salmon sperm labelled by the random-priming method [19] to a specific radio-DNA (100 ,ug/ml) at 40°C for 12 h and then hybridized at activity of about 5 RESULTS AND DISCUSSION cDNA clones encoding human peroxisomal AGT1 were isolated by screening cDNA libraries from human liver and a hepatocarcinoma cell line using rat AGT1 cDNA as the probe. The nucleotide sequence (Fig. 1 ) from two overlapping clones (A6-18, H1-2) encoded a protein of 392 amino acids with a calculated Mr of 43 046, which is in close agreement with the size of mature human peroxisomal AGT1. The identity of these clones was confirmed by comparison of the predicted amino acid sequence with the sequences of two internal peptides (DMYQIMDEIK and LPTVTTVAPAGY) generated by tryptic digestion of human AGTI. The sequence of human peroxisomal AGT1 shows about 78 % amino acid sequence identity with rat mitochondrial AGT1. The putative pyridoxal phosphate-binding lysine residue at position 209 is conserved [13] . A comparison of the 5' sequence of rat with that of human AGT1 cDNA suggests that the N-terminal 22 amino acids of the nascent rat translation product are absent from the human protein (Fig. 2) . The rat cDNA sequence encoding this 22-amino-acid extension, which is believed to be a mitochondrial-targeting signal, shows high sequence identity (74%) with the corresponding non-coding region in the human cDNA. The sequence GCTGGGAAA-TGTTCC in rat mitochondrial AGT1 cDNA around the first ATG corresponds to GCTGGGAAATATTCC in human peroxisomal AGTI cDNA, clearly indicating that the mitochondrial-targeting sequence in human AGT1 has been deleted during evolution by a single point mutation at the first ATG codon. The cDNA sequence in this region has been confirmed by analysis of the sequence of the corresponding portion of a human AGT1 genomic clone (P. E. Purdue, unpublished work). The loss of the mitochondrial targeting signal during evolution may partly explain the species differences in intracellular localization of AGT1 [2, 3, 6] .
The identical rates of evolution of peroxisomal and mitochondrial AGT1 from different species suggests that they did not arise by gene duplication [20, 21] . In rats, mature peroxisomal and mitochondrial AGT1 appear to be identical with respect to physical, enzymic and immunological properties 12,22,231. Southern-blotting analysis of rat genomic DNA suggests that there is only one gene for AGTl [24] , and preliminary data (P. E. Purdue, unpublished work) indicates that this is also the case in humans. It is likely, therefore, that the rat peroxisomal and mitochondrial AGT1 are encoded by the same gene. In this respect it is interesting to note that the two different rat AGT1 species, with and without a mitochondrial-targeting sequence, might arise from a common AGTI mRNA by translation initiation from the first (or second) and the third ATG codon respectively (Fig. 2) .
The molecular basis of targeting of AGT1 to peroxisomes is yet to be resolved. The C-terminal sequences of both human and rat AGTI (-KKKL and -KNKL respectively) are similar to the C-terminal sequence of firefly luciferase (-KSKL), the last three amino acids of which have been proposed to constitute a peroxisomal-targeting sequence [25] [26] [27] [28] . However, mutagenesis in vitro of the firefly luciferase C-terminal sequence to KKKL apparently abolishes peroxisomal-targeting activity in transfected monkey kidney-cell cultures [251. Although the effect of mutating this sequence to KNKL is not known, this does raise the possibility that other sequences are responsible for targeting AGTI to the peroxisomes.
We propose that point mutations which introduce in-frame ATG codons 5' to the human AGT1 open reading frame might be the possible mechanism by which AGT1 is diverted to the mitochondria in some PH 1 patients. Northern-blot analysis shows that there are no major differences in the size of AGT1 mRNA in PHI1 patients with the trafficking defect compared with controls (Fig. 3) Fig. 2 . Alignment of the nucleotide sequences of the 5' non-coding region of human peroxisomal AGT1 cDNA and the corresponding coding region of rat mitochondrial AGT1 cDNA
The amino acid sequences of human and rat nascent AGT1 deduced from cDNA are shown boxed. The putative mitochondrial targeting sequence of rat mitochondrial AGT1 is underlined. The N-terminal amino acid sequence of mature mitochondrial AGT1 is GSHQLLV- [13, 24] . The Nterminus of mature human peroxisomal AGT1 is blocked. species can be targeted to mitochondria will be different; and in this respect it is interesting to note that the residual levels of AGT1 in the nine definite (18 possible) PH1-trafficking-defect variants so far identified range from 5 to 50% of normal (C. J. Danpure, unpublished work).
